(Q45256702)

English

Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis

scientific article published in November 2006

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Survival of men with clinically localized prostate cancer treated with prostatectomy, brachytherapy, or no definitive treatment: impact of age at diagnosis (English)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

author name string

Jonathan D Tward

1

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Christopher M Lee

2

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Lisa M Pappas

3

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Aniko Szabo

4

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

David K Gaffney

5

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Dennis C Shrieve

6

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

language of work or name

0 references

publication date

1 November 2006

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

number of pages

9

1 reference

based on heuristic

inferred from page(s)

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

107

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

10

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

2392-2400

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

Brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

21 January 2018

Comparison of recommendations by urologists and radiation oncologists for treatment of clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Is there age bias in the treatment of localized prostate carcinoma?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Factors contributing to the racial differences in prostate cancer mortality

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical prostatectomy versus watchful waiting in early prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical prostatectomy versus brachytherapy for early-stage prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Radical prostatectomy versus high-dose rate brachytherapy for prostate cancer: effects on health-related quality of life

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

103Pd brachytherapy versus radical prostatectomy in patients with clinically localized prostate cancer: a 12-year experience from a single group practice

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Definitions of biochemical failure that best predict clinical failure in patients with prostate cancer treated with external beam radiation alone: a multi-institutional pooled analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

The correlation between the ASTRO Consensus Panel definition of biochemical failure and clinical outcome for patients with prostate cancer treated with external beam irradiation. American Society of Therapeutic Radiology and Oncology

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Failure definition-dependent differences in outcome following radiation for localized prostate cancer: can one size fit all?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

PSA nadir predicts biochemical and distant failures after external beam radiotherapy for prostate cancer: a multi-institutional analysis

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of alternative biochemical failure definitions based on clinical outcome in 4839 prostate cancer patients treated by external beam radiotherapy between 1986 and 1995.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Outcome predictors for the increasing PSA state after definitive external-beam radiotherapy for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Limitations in the use of serum prostate specific antigen levels to monitor patients after treatment for prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Determining cause of death in prostate cancer: are death certificates valid?

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

American Cancer Society Guidelines for the Early Detection of Cancer, 2005.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

American Cancer Society guidelines for the early detection of cancer, 2006.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

20-year outcomes following conservative management of clinically localized prostate cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

The changing face of low-risk prostate cancer: trends in clinical presentation and primary management

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Deferred treatment of clinically localized low-grade prostate cancer: actual 10-year and projected 15-year follow-up of the Karolinska series

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Results of conservative management of clinically localized prostate cancer.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Natural History of Early, Localized Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Lipoprotein profile in men with prostate cancer undergoing androgen deprivation therapy.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

The impact of provider volume on outcomes from urological cancer therapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Quality-of-Care Indicators for Early-Stage Prostate Cancer

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of Gleason score 3+4 versus Gleason score 4+3 tumor at radical prostatectomy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Cancer-specific mortality after surgery or radiation for patients with clinically localized prostate cancer managed during the prostate-specific antigen era.

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Biochemical outcome for hormone-naive patients with Gleason score 3+4 versus 4+3 prostate cancer undergoing permanent prostate brachytherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

10-year biochemical (prostate-specific antigen) control of prostate cancer with (125)I brachytherapy

1 reference

https://api.crossref.org/works/10.1002%2FCNCR.22261

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/CNCR.22261

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

11 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q45256702&oldid=2071813844"